Sodium glucose co-transporter 2 (SGLT2) inhibitors represent a novel class of hypoglycemic drugs that have emerged in recent years. These inhibitors function primarily by blocking the reabsorption of glucose in the kidneys, specifically targeting the SGLT2 proteins in the proximal convoluted tubules. This inhibition results in the reduction of blood glucose levels through increased glucose excretion in the urine.
View Article and Find Full Text PDFLiFeMnPO (0 < < 1) has a high operating voltage range and theoretical energy density, but its actual capacity decreased due to its low electronic conductivity. To overcome this problem, we successfully prepared LiFeMnPO/C (LFMP/C) with a uniform carbon coating by a one-step solvothermal method using bamboo shavings as the carbon source. The results showed that heating at a reaction temperature of 180 °C for 18 h was the optimal synthesis condition to obtain LFMP/C.
View Article and Find Full Text PDFDual atomic nanozymes (DAzymes) are promising for applications in the field of tumor catalytic therapy. Here, integrating with ultrasmall FeC nanoclusters, asymmetric coordination featuring Janus Zn-Fe dual-atom sites with an ON-Fe-Zn-N moiety embedded in a carbon vacancy-engineered hollow nanobox (Janus ZnFe DAs-FeC) was elaborately developed. Theoretical calculation revealed that the synergistic effects of Zn centers acting as both adsorption and active sites, oxygen-heteroatom doping, carbon vacancy, and FeC nanoclusters jointly downshifted the d-band center of Fe 3d orbitals, optimizing the desorption behaviors of intermediates *OH, thereby significantly promoting catalytic activity.
View Article and Find Full Text PDF